Selective modification of NMR relaxation time in human colorectal carcinoma by using gadolinium-diethylenetriaminepentaacetic acid conjugated with monoclonal antibody 19-9.
about
In vivo studies of Gd-DTPA-monoclonal antibody and gd-porphyrins: potential magnetic resonance imaging contrast agents for melanoma.In vivo magnetic resonance methods in pharmaceutical research: current status and perspectives.Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.Strategies for the preparation of bifunctional gadolinium(III) chelators.HER2/NEU GENE EXPRESSION PRODUCTS EVALUATED WITH SUPERPARAMAGNETIC, GENETICALLY ENGINEERED ANTIBODIESMagnetic resonance imaging (MRI) contrast agents for tumor diagnosis.
P2860
Selective modification of NMR relaxation time in human colorectal carcinoma by using gadolinium-diethylenetriaminepentaacetic acid conjugated with monoclonal antibody 19-9.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Selective modification of NMR ...... with monoclonal antibody 19-9.
@ast
Selective modification of NMR ...... with monoclonal antibody 19-9.
@en
type
label
Selective modification of NMR ...... with monoclonal antibody 19-9.
@ast
Selective modification of NMR ...... with monoclonal antibody 19-9.
@en
prefLabel
Selective modification of NMR ...... with monoclonal antibody 19-9.
@ast
Selective modification of NMR ...... with monoclonal antibody 19-9.
@en
P2093
P2860
P356
P1476
Selective modification of NMR ...... with monoclonal antibody 19-9.
@en
P2093
H Koprowski
J C Saccavini
J F Chatal
J Y Douillard
P2860
P304
P356
10.1073/PNAS.83.12.4277
P407
P577
1986-06-01T00:00:00Z